Medically reviewed by Drugs.com. Last updated on Mar 9, 2022.
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Mogamulizumab
Uses for mogamulizumab-kpkc
Mogamulizumab-kpkc injection is used to treat mycosis fungoides (MF) or Sézary syndrome (SS) that has come back or has been treated before with at least one treatment (medicine taken by mouth or injection) that did not work well.
Mogamulizumab-kpkc is to be given only by or under the direct supervision of your doctor.
Before using mogamulizumab-kpkc
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For mogamulizumab-kpkc, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to mogamulizumab-kpkc or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of mogamulizumab-kpkc injection in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mogamulizumab-kpkc injection in the elderly.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of mogamulizumab-kpkc. Make sure you tell your doctor if you have any other medical problems, especially:
- Autoimmune disease (eg, hepatitis, hypothyroidism, myocarditis, myositis, pneumonitis, polymyositis, Guillain-Barré syndrome), history of—Use with caution. May make this condition worse.
- Stem cell transplant—Use with caution. May increase risk for more side effects.
Proper use of mogamulizumab-kpkc
A nurse or other trained health professional will give you mogamulizumab-kpkc in a medical facility. It is given through a needle placed into one of your veins. Mogamulizumab-kpkc must be given slowly, so the needle will need to stay in place for at least 60 minutes.
Mogamulizumab-kpkc should come with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.
Your doctor may give you other medicines (eg, allergy medicine, fever medicine) before your first infusion of mogamulizumab-kpkc to prevent unwanted effects.
Precautions while using mogamulizumab-kpkc
It is very important that your doctor check your progress at regular visits to make sure mogamulizumab-kpkc is working properly. Blood tests may be needed to check for unwanted effects.
Using mogamulizumab-kpkc while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment with mogamulizumab-kpkc and for at least 3 months after the last dose. If you think you have become pregnant while receiving mogamulizumab-kpkc, tell your doctor right away.
Serious skin reactions can occur with mogamulizumab-kpkc. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, red skin lesions, severe acne or a skin rash, sores or ulcers on the skin, or fever or chills with mogamulizumab-kpkc.
Mogamulizumab-kpkc may cause infusion-related reactions, which can be life-threatening and require immediate medical attention. Tell your doctor right away if you start to have a fever, chills or shaking, dizziness, trouble breathing, itching or rash, lightheadedness or fainting after receiving mogamulizumab-kpkc.
Mogamulizumab-kpkc may increase your risk of infections. If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever, chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
Mogamulizumab-kpkc side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
- Black, tarry stools
- bladder pain
- bleeding gums
- blood in the urine or stools
- cloudy urine
- blurred vision
- body aches or pain
- burning, dry, or itching eyes
- burning, itching, and pain in hairy areas, pus at the root of the hair
- burning, numbness, tingling, or painful sensations
- chest pain
- cracked lips
- decreased frequency or amount of urine
- difficult or labored breathing
- difficult, burning, or painful urination
- difficulty in swallowing
- discharge, excessive tearing
- dry mouth
- ear congestion
- fast, slow, or irregular heartbeat
- flushed, dry skin
- frequent urge to urinate
- fruit-like breath odor
- increased hunger
- increased thirst
- increased urination
- itching, skin rash
- joint pain, stiffness, or swelling
- loss of appetite
- loss of voice
- lower back, side, or stomach pain
- mood or mental changes
- muscle and bone pain
- muscle spasms (tetany) or twitching seizures
- nasal congestion
- pale skin
- pinpoint red spots on the skin
- pounding in the ears
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
- runny nose
- skin blisters
- sore throat
- sores, ulcers, or white spots on the lips, tongue, or inside the mouth
- stomach pain
- swelling of the face, fingers, lower legs, or feet
- tightness in the chest
- troubled breathing with exertion
- unexplained weight loss
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual tiredness or weakness
- warmth on skin
- weakness in the arms, hands, legs, or feet
- weight gain
- Burning or stinging of the skin
- painful cold sores or blisters on the lips, nose, eyes, or genitals
- redness or swelling in the ear
- Chest discomfort
- dilated neck veins
- extreme tiredness or weakness
- irregular breathing
- pain or discomfort in the arms, jaw, back, or neck
Incidence not known
- Dark urine
- general tiredness and weakness
- light-colored stools
- upper right abdominal pain
- yellow eyes and skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- decreased appetite
- feeling sad or empty
- loss of interest or pleasure
- thinning or loss of hair
- trouble concentrating
- trouble sleeping
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Frequently asked questions
More about mogamulizumab
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- En español
- Drug class: miscellaneous antineoplastics
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.